The Analytical Scientist
Spokesperson: Andrew James, Ellutia
In many regions, cannabis is now considered by the public as a medicine. However, compared to pharmaceutical industry standards, it is easy to see where it falls short in terms of rigorous safety and potency testing. Andrew James, Marketing Director at Ellutia, discusses the need for more in-house testing throughout the supply chain. Read the article here.